Follow-up Study for Subjects Enrolled on Genitope Protocol 2000-03 (IUPUI IRB protocol 0102-26) A Phase III Trial to Evaluate the Safety and Efficacy of Specific Immunotherapy, Recombinant Idiotype Conjugated to KLH with GM-CSF, Compared to Non-Specific Immunotherapy, KLH With GM-CSF, In Patients with Follicular Non-Hodgkin's Lymphoma

A PHASE III, RANDOMIZED STUDY OF NIVOLUMAB (OPDIVO) PLUS AVD OR BRENTUXIMAB VEDOTIN (ADCETRIS) PLUS AVD IN PATIENTS (AGE >/= 12 YEARS) WITH NEWLY DIAGNOSED ADVANCED STAGE CLASSICAL HODGKIN LYMPHOMA NCT# 03907488